Raymond James & Associates’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$214K Sell
2,034
-1,766
-46% -$180K ﹤0.01% 3606
2024
Q2
$354K Buy
3,800
+161
+4% +$17.1K ﹤0.01% 3272
2024
Q1
$474K Buy
3,639
+1,023
+39% +$120K ﹤0.01% 3092
2023
Q4
$296K Buy
2,616
+116
+5% +$10.1K ﹤0.01% 3284
2023
Q3
$205K Buy
+2,500
New +$220K ﹤0.01% 3436
2021
Q4
Sell
-7,410
Closed -$362K 4150
2021
Q3
$362K Sell
7,410
-200
-3% -$10.1K ﹤0.01% 3287
2021
Q2
$383K Sell
7,610
-3,790
-33% -$186K ﹤0.01% 3263
2021
Q1
$447K Sell
11,400
-2,925
-20% -$114K ﹤0.01% 3106
2020
Q4
$419K Sell
14,325
-605
-4% -$15.5K ﹤0.01% 2926
2020
Q3
$321K Buy
14,930
+1,400
+10% +$22.6K ﹤0.01% 2914
2020
Q2
$116K Buy
+13,530
New +$83.6K ﹤0.01% 3258

Other funds holding BXC

Raymond James & Associates's BXC Position: Q3 2024 in Review

Raymond James & Associates reduced its BlueLinx (BXC) stake by 46% in Q3 2024, selling an estimated $180K and leaving 2,034 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #3606.

Raymond James & Associates first reported a position in BXC in Q2 2020 and has held it in 11 quarters since. The position peaked at $474K in Q1 2024. 167 funds tracked by Wall St. Rank hold BXC as of Q3 2024.

  • Raymond James & Associates held 2,034 shares of BlueLinx worth $214K as of Q3 2024.
  • Raymond James & Associates sold 1,766 BlueLinx shares in Q3 2024, an estimated $180K.
  • BlueLinx made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3606 holding.
  • Raymond James & Associates first reported a position in BlueLinx in Q2 2020 and has held it in 11 quarters since.
  • Raymond James & Associates's BlueLinx position peaked at $474K in Q1 2024.
  • 167 funds tracked by Wall St. Rank held BlueLinx as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.